Globally, the pharmaceutical and life sciences industry is one of the world’s most important sectors and one of the key contributors to the global economy. In research recently conducted by PricewaterhouseCoopers for the report
Pharma 2020: The vision: Which path will you take? the firm estimates that the global market for pharmaceutical products (excluding medical devices) will more than double in sales to $1.3 trillion by the year 2020.
While the G7 countries will continue to be the primary markets driving PLS growth, the E7 countries (Brazil, China, India, Indonesia, Mexico, Russia and Turkey) are steadily becoming more prosperous, with GDP projected to triple over the next 13 years. The E7 are expected to account for as much as one-fifth of global pharmaceutical sales by 2020 – a 60 percent increase since 2004.
